Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

On August 20th, 2024, the Ontario provincial government announced new legislation that would force the closure of most of Ontario’s 17 supervised consumption services (SCS).

Report | 2024
About PWUD, Advocacy, Crime, Evidence base, Harm reduction, Housing, Illegal drugs, Injecting drugs, Mortality, Overdose, Policy/Regulatory, SCS/OPS, Social benefits, Social services, Wrap-around services

To provide guidance on evidence-based strategies for the treatment of stimulant use disorders (StUDs), stimulant intoxication, and stimulant withdrawal, as well as se

Guidelines | 2024
About PWUD, Clinical guidance, Hospitals, Illegal drugs, Return to use, Stimulants, Substitution/OAT, Transitions in care/treatment, Withdrawal, Wrap-around services

This paper reports on the evaluation of the Digital Lifelines Scotland program, which provides underserved people who use/d drugs with digital devices to connect with services. 

Original research | 2024
About PWUD, Barriers and enablers, Digital health, Equity, Harm reduction, Illegal drugs, Overdose, Peer/PWLLE program involvement, Wrap-around services
Commentary | 2022
About prescribers, Chronic pain, Clinical guidance, Hesitancy of prescribers , Outcomes, Withdrawal

To describe the implementation and short-term outcomes of an outpatient benzodiazepine taper protocol to treat benzodiazepine withdrawal in a substance use disorder bridge clinic.

Original research | 2024
About PWUD, Benzodiazepines, Clinical guidance, Mortality, Overdose, Return to use, Withdrawal, Wrap-around services

This study characterized xylazine awareness, desire, use and exposure among people who use drugs (PWUD) in Rhode Island, US, at a local drug checking service. 

Original research | 2024
About PWUD, Drug checking, Harm reduction, Illegal drugs, Injecting drugs
Other | 2024
About PWUD, Advocacy, Barriers and enablers, Carries/take-home doses, Peer/PWLLE program involvement, Safer supply, Injecting drugs, Substitution/OAT

Several resources were developed collaboratively with service users, providers, research team members, and partners across Canada to mobilize the knowledge produced t

Other | 2024
About pharmacists, About prescribers, Barriers and enablers, Carries/take-home doses, Clinical guidance, Illegal drugs, Injecting drugs, Peer/PWLLE program involvement, Policy/Regulatory, Substitution/OAT, Withdrawal, Wrap-around services

To determine if and how Supervised Consumption Sites (SCS) lower local real estate prices and attract people who use drugs (PWUD) to the area.

Original research | 2024
Advocacy, Barriers and enablers, Evidence base, Harm reduction, Illegal drugs, Injecting drugs, Housing, Stigma, SCS/OPS, Wrap-around services

This alert identifies the emergence of nitazenes in the illicit drug supply.

Infographic | 2022
Advocacy, Drug checking, Illegal drugs, Harm reduction, Overdose, Opioids

It is unknown how many people in treatment for opioid use disorder (OUD) have naloxone, use naloxone, and what their perceptions and barriers to obtaining it are. 

Original research | 2024
About PWUD, Digital health, Harm reduction, Wrap-around services

This report is grounded in lived experience, and aims to provide a history of methadone therapy (MT) in the United States, to summarize the conference proceedings tha

Report | 2024
Advocacy, Barriers and enablers, Clinical guidance, Diversion, Equity, Overdose, Peer/PWLLE program involvement, Policy/Regulatory, Safer supply, Substitution/OAT

To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and

Original research | 2017
About PWUD, Mortality, Outcomes, Overdose, Return to use, Substitution/OAT, Transitions in care/treatment, Withdrawal

This webinar exists to kick off the research report (linked on webinar webpage) about opioid-related toxicity deaths in homeless shelters.

Archived webinar | 2024
About PWUD, Barriers and enablers, Clinical guidance, Harm reduction, Hospitals, Housing, Illegal drugs, Mortality, Overdose, Poverty, Social benefits, Social services

This article discusses the origins of the overdose epidemic- and how it is not just the result of overprescribing in the early 2000's.

Commentary | 2022
About prescribers, Outcomes, Overdose

Involuntary care is permitted in BC for the treatment of substance use disorders, however there is insufficient understanding of the perspectives of people who use drugs (PWUD) on this approach, an

Original research | 2021
About PWUD, Barriers and enablers, Clinical guidance, Illegal drugs, Peer/PWLLE program involvement, Policy/Regulatory, Social services, Transitions in care/treatment, Withdrawal

This study sought to trace the historical development and evolution of the concept of a public health approach to substance use in Canada through a critical review of the academic literature.

Lit review | 2024
Advocacy, Illegal drugs, Policy/Regulatory, Decriminalization/legalization, Legal system/law enforcement

The MySafe program provides pharmaceutical-grade opioids to participants via biometric dispensing machines. This study examines program-related goals and related outcomes across time.

Original research | 2024
About PWUD, Barriers and enablers, Evidence base, Harm reduction, Injecting drugs, Safer supply, Wrap-around services

This is a compilation of information and recommendations for the implementation and use of SROM in OAT. 

Guidelines | 2023
Substitution/OAT, Carries/take-home doses, Chronic pain, Clinical guidance, Transitions in care/treatment

The two main objectives are: (1) Provide comparable, valid and up-to-date data on costs and harms of substance use in Canada, and (2) to allow people to actively expl

Webpage | 2023
Advocacy, Evidence base, Illegal drugs

Affiner votre recherche

Mots clés
Format
Région